Table 1 Clinicopathological features of T1b2 gastric cancer.

From: Preceding endoscopic submucosal dissection in submucosal invasive gastric cancer patients does not impact clinical outcomes

Variables

Total

248 cases 254 lesion

ESD + additional surgery

101 cases 102 lesion

Surgery

147 cases 152 lesion

P value

Sex

 < 0.01

Male

173 (70)

80 (79)

93 (63)

 

Female

75 (30)

21 (21)

54 (37)

 

Age (years)

67.8 ± 11.0

69.4 ± 10.1

67.0 ± 11.5

0.048

Location 1

 < 0.01

Upper third

62 (24)

30 (30)

32 (21)

 

Middle third

118 (47)

32 (31)

86 (57)

 

Lower third

68 (27)

37 (36)

31 (20)

 

Remnant stomach

6 (2)

3 (3)

3 (2)

 

Location 2

n.s

Anterior

50 (20)

17 (17)

33 (22)

 

Posterior

61 (24)

21 (21)

40 (26)

 

Greater curvature

63 (25)

27 (26)

36 (24)

 

Lesser curvature

80 (31)

37 (36)

43 (28)

 

Tumor diameter (mm)

29.5 ± 21.1

24.9 ± 18.0

32.6 ± 22.5

 < 0.01

Macroscopic type

0.02

Elevated

69 (27)

36 (35)

33 (22)

 

Depressed

185 (73)

66 (65)

119 (78)

 

Main histopathological type

 < 0.01

Differentiated

159 (63)

81 (79)

78 (51)

 

Undifferentiated

95 (37)

21 (21)

74 (49)

 

Depth of SM invasion (μm)

1651 ± 1024

1348 ± 841

1855 ± 1087

 < 0.01

Lymphatic invasion

n.s

Positive

88 (35)

30 (29)

58 (38)

 

Negative

166 (65)

72 (71)

94 (62)

 

Venous invasion

n.s

Positive

42 (17)

16 (16)

26 (17)

 

Negative

212 (73)

86 (84)

126 (83)

 

Lymph node metastasis

n.s

Positive

41 (16)

16 (16)

25 (16)

 

Negative

213 (84)

86 (84)

127 (84)